Limitations of the murine nose in the development of nonviral airway gene transfer

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 1, 2010, Pages 46-54

  Griesenbach, Uta ^a,b,g   Sumner Jones, Stephanie G ^a,c,g   Holder, Emma ^a,d,g   Munkonge, Felix M ^a,b,g   Wodehouse, Theresa ^a,b,g   Smith, Stephen N ^a,b,g   Wasowicz, Marguerite Y ^a,b,g   Pringle, Ian ^a,c,g   Casamayor, Isabel ^a,b,g   Chan, Mario ^a,b,g   Coles, Rebecca ^a,c,g   Cornish, Nikki ^a,b,g   Dewar, Ann ^e   Doherty, Ann ^a,d,g   Farley, Raymond ^a,b,g   Green, Anne Marie ^a,c,g   Jones, Bryony L ^a,c,g   Larsen, Mia D B ^a,b,g   Lawton, Anna E ^a,c,g   Manvell, Michelle ^a,b,g   Painter, Hazel ^a,c,g   Singh, Charanjit ^a,b,g   Somerton, Lucinda ^a,b,g   Stevenson, Barbara ^a,d,g   Varathalingam, Anusha ^a,c,g   Siegel, Craig ^f   Scheule, Ronald K ^f   Cheng, Seng H ^f   Davies, Jane C ^a,b,g   Porteous, David J ^a,d,g   Gill, Deborah R ^a,c,g   Boyd, A Christopher ^a,d,g   Hyde, Steve C ^a,c,g   Alton, Eric W F W ^a,b,g   more..

^a UK Cystic Fibrosis Gene Therapy Consortium   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f GENZYME CORPORATION   (United States)

^g United Kingdom Cystic Fibrosis Gene Therapy Consortium London   (United Kingdom)

Author keywords

Cystic fibrosis; Gene therapy; Liposomes; Mice

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM ADHERENCE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; ION TRANSPORT; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOSE; NOSE MUCOSA; PHENOTYPE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BACTERIAL ADHESION; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NOSE; PLASMIDS; PROMOTER REGIONS, GENETIC;

ANIMALIA; BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; MURINAE; MUS;

EID: 78349257399     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0075OC     Document Type: Article

References (39)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073. (Pubitemid 19231814)
2. Drumm ML, Pope HA, Cliff WH, Rommens JM, Marvin SA, Tsui LC, Collins FS, Frizzell RA, Wilson JM. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990;62:1227-1233.
3. Hyde SC, Gill DR, Higgins CF, Trezise AE, MacVinish LJ, Cuthbert AW, Ratcliff R, Evans MJ, Colledge WH. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993;362:250-255.
4. Alton EW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, Jeffery PK, Geddes DM, Hart SL, Williamson R, et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993;5:135-142.
5. Ferrari S, Griesenbach U, Geddes DM, Alton E. Immunological hurdles to lung gene therapy. Clin Exp Immunol 2003;132:1-8.
6. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996;7:1701-1717.
7. Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, DaviesMG, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999;353:947-954.
8. Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR, et al. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther 2001;12:751-761.
9. Dorin JR. Animal models. In: Bush A, Alton EW, Davies JC, Griesenbach U, Jaffe A, editors. Progress in respiratory research: cystic fibrosis in the 21st century. Basel, Swizerland: Karger; 2006. pp. 84-92.
10. Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 1994;266:1705-1708.
11. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001;8:1539-1546.
12. Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Sumner-Jones SG, et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 2008;26:549-551.
13. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JA, Smith JA, Stuhl K. Current protocols in molecular biology, 2nd ed. Hoboken, NJ: John Wiley & Sons, 1Inc.; 1996.
14. Derand R, Bulteau-Pignoux L, Becq F. Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004. J Membr Biol 2003;194:109-117. (Pubitemid 37092635)
15. Rose AC, Goddard CA, Colledge WH, Cheng SH, Gill DR, Hyde SC. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Gene Ther 2002;9:1312-1320.
16. Smith SN, Middleton PG, Chadwick S, Jaffe A, Bush KA, Rolleston S, Farley R, Delaney SJ, Wainwright B, Geddes DM, et al. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects. Am J Respir Cell Mol Biol 1999;20:129-134. (Pubitemid 129504851)
17. Davies JC, Stern M, Dewar A, Caplen NJ, Munkonge FM, Pitt T, Sorgi F, Huang L, Bush A, Geddes DM, et al. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Respir Cell Mol Biol 1997;16:657-663. (Pubitemid 127498941)
18. Scheule RK, St. George JA, Bagley RG, Marshall J, Kaplan JM, Akita GY, Wang KX, Lee ER, Harris DJ, Jiang C, et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 1997;8:689-707. (Pubitemid 27202056)
19. Jiang C, O'Connor SP, Fang SL, Wang KX, Marshall J, Williams JL, Wilburn B, Echelard Y, Cheng SH. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum Gene Ther 1998;9:1531-1542. (Pubitemid 28382955)
20. O'Riordan CR, Lachapelle AL, Marshall J, Higgins EA, Cheng SH. Characterization of the oligosaccharide structures associated with the cystic fibrosis transmembrane conductance regulator. Glycobiology 2000;10:1225-1233.
21. Griesenbach U, Smith SN, Farley R, Singh C, Alton EW. Validation of nasal potential difference measurements in gut-corrected CF knockout mice. Am J Respir Cell Mol Biol 2008;39:490-496.
22. Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995;1:39-46.
23. Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther 2002;5:413-419. (Pubitemid 34308666)
24. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, Cohn JA, Wilson JM. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992;2:240-248.
25. Fang X, Song Y, Hirsch J, Galietta LJ, Pedemonte N, Zemans RL, Dolganov G, Verkman AS, Matthay MA. Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. Am J Physiol Lung Cell Mol Physiol 2006;290:L242-L249.
26. Holder E, Stevenson B, Farley R, Hilliard T, Wodehouse T, Somerton L, Larsen M, O'Donoghue J, Coles RL, Scheule RK, et al. Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity. J Gene Med 2010;12:55-63.
27. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. Science 1992;257:1083-1088.
28. Davies JC, Wodehouse T, Farley R, Griesenbach U, Wainwright B, Geddes DM, Alton EW. Adherence of Pseudomonas aeruginosa is increased to nasal epithlial cells from cystic fibrosis mice [abstract]. Ped Pulm 2005;50(S28):259.
29. Tarran R, Grubb BR, Gatzy JT, Davis CW, Boucher RC. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol 2001;118:223-236. (Pubitemid 32744527)
30. Griesenbach U, Larsen M, Smith S, Dewar A, Farley R, Singh C, Geddes DM, Alton EW. Airway surface liquid height and nasal potential difference measurement in FABp-CF knockout mice: a core facility for screening of non-viral gene transfer agents [abstract]. Thorax 2004;50(S2):ii27.
31. Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard CA, Hannavy K, Smyth SE, et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 2000;7:1156-1165.
32. Dorin JR, Farley R, Webb S, Smith SN, Farini E, Delaney SJ, Wainwright BJ, Alton EW, Porteous DJ. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther 1996;3:797-801. (Pubitemid 26326685)
33. Johnson LG, Olsen JC, Sarkadi B, Moore KL, Swanstrom R, Boucher RC. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992;2:21-25.
34. - transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 2005;289:L1123-L1130.
35. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-1676.
36. Ferrari S, Griesenbach U, Iida A, Farley R, Wright AM, Zhu J, Munkonge FM, Smith SN, You J, Ban H, et al. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther 2007;14:1371-1379.
37. Griesenbach U, Cassady RL, Ferrari S, Fukumura M, Muller C, Schmitt E, Zhu J, Jeffery PK, Nagai Y, Geddes DM, et al. The nasal epithelium as a factory for systemic protein delivery. Mol Ther 2002;5:98-103. (Pubitemid 34144825)
38. Ostrowski LE, Yin W, Diggs PS, Rogers TD, O'Neal WK, Grubb BR. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Gene Ther 2007;14:1492-1501. (Pubitemid 47500652)
39. Grubb BR, Rogers TD, Kulaga HM, Burns KA, Wonsetler RL, Reed RR, Ostrowski LE. Olfactory epithelia exhibit progressive functional and morphological defects in CF mice. Am J Physiol Cell Physiol 2007;293:C574-C583.